BorjeS.AnderssonMD

PubMed

• High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomas.
  Jeremy Ramdial, Ruitao Lin, Peter F Thall, Benigno C Valdez, Chitra Hosing
  Bone Marrow Transplantation. 2024-12-01
• Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor-specific antibody prior to haploidentical transplantation.
  Nuttra Suwantarat, Pornchanok Iamsirirak, Jiraporn Chanapai, Samart Pakakasama, Borje S Andersson
  Pediatric Blood & Cancer. 2024-11-01
• Synergistic Cytotoxicity of Histone Deacetylase and Poly-ADP Ribose Polymerase Inhibitors and Decitabine in Breast and Ovarian Cancer Cells: Implications for Novel The...
  Benigno C Valdez, Apostolia M Tsimberidou, Bin Yuan, Mehmet A Baysal, Abhijit Chakraborty
  International Journal of Molecular Sciences. 2024-08-26

Journal Articles

• Impact of a Novel Prognostic Model, Hematopoietic Cell Transplant-Composite Risk (HCT-CR), on Allogeneic Transplant Outcomes in Patients with Acute Myeloid Leukemia an...  
  Uday Popat, Chitra M Hosing, Issa Khouri, Richard Champlin, Simrit Parmar, Partow Kebriaei, Borje S Andersson, Qaiser Bashir, Amin Alousi, Nature

Abstracts/Posters

• Decitabine As Part of a Modified Bu-Cy Conditioning Regimen Significantly Improved the Outcome of High-Risk AML Patients Undergoing Allogeneic Hematopoietic Stem Cell ...
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Allogeneic Cord Blood Regulatory T Cells Can Prevent Graft Vs. Host Disease and Preserve Graft Vs Leukemia Effect: Update on Phase I/II Clinical Trial
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Randomized Study of Fludarabine-Clofarabine Vs Fludarabine Alone Combined with Busulfan and Allogeneic Hematopoietic Transplantation for AML and MDS
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Third-Party BK Virus Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Myeloablative Fractionated Busulfan Conditioning Regimen in Older Patients: Results of a Phase II Study
  Borje S Andersson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Hematopoietic Cell Transplant -Composite Risk (HCT-CR) - a Novel Prognostic Model to Predict Transplant Outcomes 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018